Skip to content
lifestyle.smsolar.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
NetraMark Holdings Inc.
Peer-Reviewed Study Published in MDPI’s AI Journal Shows NetraAI Uncovers Clinical Trial Signals Missed by Conventional AI and Foundation Models
September 10, 2026
NetraMark Appoints Finance Expert Kevin Felix as Strategic Advisor
September 8, 2026
NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier
September 1, 2026
NetraMark to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
August 27, 2026
NetraMark Corporate Update Highlights Record C$3.4 Million in Fiscal 2026 Contract Bookings, Up 645% from Previous Annual High
August 20, 2026
NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness
July 13, 2026
NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner
July 9, 2026
NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company
June 29, 2026
NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026
June 9, 2026
NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum
May 15, 2026
1
2
Next Page
→